Oceanpine Capital is to acquire an 80% equity stake in Beijing Jacoray Pharmaceutical Technology for a total consideration of 200m yuan ($28m). The move is part of Jacobio Pharma’s subsidiary Beijing Jacobio Pharmaceuticals’ capital increase and equity transfer agreement signed with Oceanpine Capital and an industry partner. The deal value is an upfront payment of 125m yuan, with an additional 75m yuan to be paid as a milestone payment in a second instalment. Upon completion, Oceanpine Capital will hold ...